Genentech finds non-exhausted antitumor T cell source in blood, plus updates on Penn and Chordoma Foundation-Mark Foundation

BioCentury’s roundup of preclinical news

Genentech identifies blood as source of antitumor T cells
In a Nature article, a Genentech Inc. team reported that non-exhausted T cell clones in the blood could act as a source of antitumor T

Read the full 357 word article

How to gain access

Continue reading with a
two-week free trial.